🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Congratulations to my trainee Michelle Bookstaver for being awarded the Cancer Research Institute Fellowship to Promote Racial Diversity! Super proud to be mentoring a Native American woman scientist. Women in STEM rock!

Gave my first scientific talk in Spanish today. Thank you Ignacio Melero for bringing the Spanish-speaking Cancer Immunology together. Hasta la próxima!

#SITC22 Science Highlight: Join Ana Anderson lab Kuchroo Lab Harvard Medical School and Ira Mellman, Phd Genentech in Session 212: Next Generation Checkpoint Blockade: Mechanisms of Action. Schedule:ow.ly/j5Ke50K5Rij

Honored to co-author this review on steroid hormone regulation of immune responses in cancer with my former trainee Nandini Acharya

Welcome to Boston Society for Immunotherapy of Cancer! Looking forward to the next few days of exciting research presentations!

Very proud of my trainees Davide Mangani, PhD and Giulia Escobar on being awarded Young Investigator travel awards Society for Immunotherapy of Cancer!

Proud to be named a Highly Cited Researcher 2022 by Clarivate for Academia & Government. See the full list bit.ly/3fPhNLo #HighlyCited2022

Congratulations to Stefani Spranger and Maria Zagorulya on the beautiful work and cover! Go women in STEM!

Going back to my roots in autoimmunity with Davide Mangani, PhD and Dandan Yang! Happy to share our review on T cells in autoimmunity and cancer. Out today in Immunity authors.elsevier.com/a/1gbHW3qNrUu3…

Amazing way to cap off two days of hard but important work deciding the future directions of cancer immunotherapy with Society for Immunotherapy of Cancer and Saman Maleki, PhD 🇨🇦 @CVanpouilleBox @deborahcollyar and others.

Great presentation. I learned so much! Thank you @deborahcollyar for enlightening us!

Apparently I was beat to the punch! Very proud of Giulia Escobar who spearheaded our understanding of the rules governing reliance on TCF1 for anti-tumor responses upon checkpoint blockade therapy! Many thanks to our collaborator LucaBiasco and all lab members who contributed!

Congratulations to Prof. Madi! Our great next door neighbor and a wonderful scientist and collaborator ! Looking forward to celebrating this! 🎉🍾🥂

The Society for Immunotherapy of Cancer (SITC) is pleased to offer a free educational program crafted specifically for international audiences, titled “Increasing Access to IO: A Global Webinar Series”. To learn more about the series visit sitcancer.org/Global-AccessF…

Our work "Pan-cancer mapping of single CD8+ T cells profiles reveals a TCF1:CXCR6 axis regulating CD28 co-stimulation and anti-tumor immunity." is now online @cellrepmed and highlighted here bwhclinicalandresearchnews.org/2024/07/02/res….

Happy to announce that I am officially promoted to Full Professor at Harvard Medical School! A very special thank you to my mentor Kuchroo Lab and my trainees who trusted me with their careers!

Love this depiction of our work! Thank you ImmunoSketch

In recent research, Ana Anderson lab and collaborators identify a major regulator of Th17 cell state, The findings have implications for multiple autoimmune diseases. The work was published in Cell Press. Read more: buff.ly/48o8lp0